from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1625c/cya

LFCtreatmentdescriptionclass of inhibitor

-1.020

Amikacinug/mL Amikacintranslation

-1.394

Cap5-10ug/mL Capreomycintranslation

-1.378

Rox10-50 ug/mL Roxithromycintranslation

-1.077

SM2-5 ug/mL Streptomycintranslation

-0.888

Tet5-10 ug/mL Tetracyclinetranslation

-0.417

Rif0.2-5ug/mL Rifampicintranscription

-0.612

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.396

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.124

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.187

CPZ10-50 ug/mL Chlorpromazinerespiration

1.375

Clofazimine10-13 ug/mL Clofaziminerespiration

0.354

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.567

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.377

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.424

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.561

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.322

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.922

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.776

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.595

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.356

KCN5-20 ug/mL Potassium cyaniderespiration

0.753

NaN30.2-2 mM Sodium aziderespiration

-0.438

Nigericin50 uM Nigericinrespiration

0.927

TRC10-150 ug/mL Triclosanrespiration

1.002

TRZ10-25 ug/mL Thioridazinerespiration

-1.459

Valinomycin0.5-10 uM Valinomycinrespiration

-0.259

ZnSO42 mM ZnSO4respiration

-0.292

menadione6-10 ug/mL Menadionerespiration

0.063

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.700

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.268

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.386

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.392

NRP_1Non-replicating persistence stage 1dosRassociated

-0.339

Amp0.2mg/mL AmpicillincellWall

-0.563

Cephalexin20-100 ug/mL CephalexincellWall

-0.101

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.466

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.308

EMB10-20 ug/mL EthambutolcellWall

-0.441

Eta12-40 ug/mL EthionamidecellWall

-0.609

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.495

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.249

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.121

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.347

BZA0.12 mg/mL BenzamidearomaticAmides

0.020

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.054

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.483

H2O24 mM hydrogen peroxideDNAdamaging

-0.514

Levo10 ug/mL LevofloxacinDNAdamaging

-0.838

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.276

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.477

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.783

UVUV-irradiationDNAdamaging

-0.648

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.313

Antimycin12.5-50 ug/mL Antimycin A?

-0.368

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.207

PA_110-50 ug/mL Antitubercular compound PA-1?

0.043

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.404

PA8240.2-2 ug/mL PA-824?

0.788

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.008

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.221

Verapamil50 uM Verapamil?

-0.455

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.392

methoxatin10-20 ug/mL Methoxatin?